Involvement of Proteasome in the Dynamic Assembly of the Androgen Receptor Transcription Complex*

We have used the chromatin immunoprecipitation technique to analyze the formation of the androgen receptor (AR) transcription complex onto prostate-specific antigen (PSA) and kallikrein 2 promoters in LNCaP cells. Our results show that loading of holo-AR and recruitment of RNA polymerase II to the promoters occur transiently. The cyclic nature of AR transcription complex assembly is also illustrated by transient association of coactivators GRIP1 and CREB-binding protein and acetylated histone H3 with the PSA promoter. Treatment of cells with the pure antiandrogen bicalutamide also elicits occupancy of the promoter by AR. In contrast to the agonist-liganded AR, bicalutamide-bound receptor is not capable of recruiting polymerase II, GRIP1, or CREB-binding protein, indicating that the conformation of AR bound to anti-androgen is not competent to assemble transcription complexes. Proteasome is involved in the regulation of AR-dependent transcription, as a proteasome inhibitor, MG-132, prevents the release of the receptor from the PSA promoter, and it also blocks the androgen-induced PSA mRNA accumulation. Furthermore, occupancy of the PSA promoter by the 19 S proteasome subcomplex parallels that by AR. Collectively, formation of the AR transcription complex, encompassing AR, polymerase II, and coactivators, on a regulated promoter is a cyclic process involving proteasome function.

[1]  D. Budman,et al.  Phosphorylation/dephosphorylation of androgen receptor as a determinant of androgen agonistic or antagonistic activity. , 1999, Biochemical and biophysical research communications.

[2]  D. Sharma,et al.  Ordered recruitment of histone acetyltransferases and the TRAP/Mediator complex to thyroid hormone-responsive promoters in vivo , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[3]  Miguel Beato,et al.  Steroid hormone receptors: Many Actors in search of a plot , 1995, Cell.

[4]  C. Allis,et al.  Gene regulation: Code of silence , 2001, Nature.

[5]  J. Palvimo,et al.  Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1). , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[6]  E. Wilson,et al.  Agonist and antagonist activities of hydroxyflutamide and Casodex relate to androgen receptor stabilization. , 1996, Urology.

[7]  P. Chambon,et al.  Phosphorylation by p38MAPK and recruitment of SUG‐1 are required for RA‐induced RARγ degradation and transactivation , 2002, The EMBO journal.

[8]  C. Lange,et al.  Phosphorylation of human progesterone receptors at serine-294 by mitogen-activated protein kinase signals their degradation by the 26S proteasome. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[9]  B. O’Malley,et al.  Proteasome-dependent degradation of the human estrogen receptor. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[10]  C. Glass,et al.  The coregulator exchange in transcriptional functions of nuclear receptors. , 2000, Genes & development.

[11]  T. Yanase,et al.  The Subnuclear Three-dimensional Image Analysis of Androgen Receptor Fused to Green Fluorescence Protein* , 2001, The Journal of Biological Chemistry.

[12]  M. Koken,et al.  Retinoic Acid Induces Proteasome-Dependent Degradation of Retinoic Acid Receptor α (RARα) and Oncogenic RARα Fusion Proteins , 1999 .

[13]  L. Freedman,et al.  Reciprocal Recruitment of DRIP/Mediator and p160 Coactivator Complexes in Vivo by Estrogen Receptor* , 2002, The Journal of Biological Chemistry.

[14]  M. Gilman,et al.  Proteasome‐mediated degradation of transcriptional activators correlates with activation domain potency in vivo , 1999, The EMBO journal.

[15]  Li Zhao,et al.  Hormone binding induces rapid proteasome-mediated degradation of thyroid hormone receptors. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[16]  B. Emerson,et al.  Mechanisms of chromatin assembly and transcription. , 2002, Current opinion in cell biology.

[17]  T. Fujiwara,et al.  CDNA cloning of p112, the largest regulatory subunit of the human 26s proteasome, and functional analysis of its yeast homologue, sen3p. , 1996, Molecular biology of the cell.

[18]  F. S. French,et al.  Androgen receptor defects : Historical, clinical, and molecular perspectives , 1995 .

[19]  J. Mocco,et al.  Molecular analysis of the prostate‐specific antigen upstream gene enhancer , 2001, The Prostate.

[20]  J. Trapman,et al.  Two Androgen Response Regions Cooperate in Steroid Hormone Regulated Activity of the Prostate-specific Antigen Promoter (*) , 1996, The Journal of Biological Chemistry.

[21]  O. Jänne,et al.  Pure antiandrogens disrupt the recruitment of coactivator GRIP1 to colocalize with androgen receptor in nuclei , 2002, FEBS letters.

[22]  J. Cidlowski,et al.  Proteasome-mediated Glucocorticoid Receptor Degradation Restricts Transcriptional Signaling by Glucocorticoids* , 2001, The Journal of Biological Chemistry.

[23]  W. Kraus,et al.  A role for coactivators and histone acetylation in estrogen receptor α‐mediated transcription initiation , 2001, The EMBO journal.

[24]  Shaobo Zhang,et al.  An androgen response element mediates LNCaP cell dependent androgen induction of the hK2 gene , 2000, Molecular and Cellular Endocrinology.

[25]  O. Jänne,et al.  Interaction of Androgen Receptors with Androgen Response Element in Intact Cells , 1997, The Journal of Biological Chemistry.

[26]  R. Kingston,et al.  ATP-dependent remodeling and acetylation as regulators of chromatin fluidity. , 1999, Genes & development.

[27]  O. Jänne,et al.  The RING finger protein SNURF modulates nuclear trafficking of the androgen receptor. , 2000, Journal of cell science.

[28]  C. Robson,et al.  Tip60 Is a Co-activator Specific for Class I Nuclear Hormone Receptors* , 2001, The Journal of Biological Chemistry.

[29]  T. Kodadek,et al.  The 19S regulatory particle of the proteasome is required for efficient transcription elongation by RNA polymerase II. , 2001, Molecular cell.

[30]  Y. Shang,et al.  Formation of the androgen receptor transcription complex. , 2002, Molecular cell.

[31]  J. Gustafsson,et al.  Interaction of the human androgen receptor transactivation function with the general transcription factor TFIIF. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[32]  M. Gleave,et al.  Ligand-independent activation of the androgen receptor by the differentiation agent butyrate in human prostate cancer cells. , 2000, Cancer research.

[33]  H. Klocker,et al.  Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor and epidermal growth factor. , 1995, European urology.

[34]  A. Weissman Ubiquitin and proteasomes: Themes and variations on ubiquitylation , 2001, Nature Reviews Molecular Cell Biology.

[35]  T. Hill,et al.  Different proportions of various prostate‐specific antigen (PSA) and human kallikrein 2 (hK2) forms are present in noninduced and androgen‐induced LNCaP cells , 2000, The Prostate.

[36]  F. J. Herrera,et al.  Proteasome Parts at Gene Promoters , 2002, Science.

[37]  K. Yamamoto,et al.  The glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain. , 2000, Genes & development.

[38]  J. Overbaugh,et al.  Evidence that an IRES within the Notch2 coding region can direct expression of a nuclear form of the protein. , 2000, Molecular cell.

[39]  Chawnshang Chang,et al.  From Androgen Receptor to the General Transcription Factor TFIIH , 2000, The Journal of Biological Chemistry.

[40]  Thomas Kodadek,et al.  Recruitment of a 19S Proteasome Subcomplex to an Activated Promoter , 2002, Science.

[41]  O. Hermanson,et al.  Nuclear receptor coregulators: multiple modes of modification , 2002, Trends in Endocrinology & Metabolism.

[42]  A. Caudy,et al.  Regulation of Transcriptional Activation Domain Function by Ubiquitin , 2001, Science.

[43]  M. Grunstein,et al.  Mapping DNA interaction sites of chromosomal proteins using immunoprecipitation and polymerase chain reaction. , 1999, Methods in enzymology.

[44]  A. Sarasin,et al.  XPD Mutations Prevent TFIIH-Dependent Transactivation by Nuclear Receptors and Phosphorylation of RARα , 2002, Cell.

[45]  M. Beato,et al.  Interaction of steroid hormone receptors with the transcription initiation complex. , 1996, Endocrine reviews.

[46]  R. Conaway,et al.  Emerging Roles of Ubiquitin in Transcription Regulation , 2002, Science.

[47]  Myles Brown,et al.  Cofactor Dynamics and Sufficiency in Estrogen Receptor–Regulated Transcription , 2000, Cell.

[48]  D. Tindall,et al.  Tissue-specific and hormonal regulation of human prostate-specific glandular kallikrein. , 1992, Biochemistry.

[49]  S. Saccani,et al.  Two Waves of Nuclear Factor κb Recruitment to Target Promoters , 2001, The Journal of experimental medicine.

[50]  U. Hansen,et al.  Binding of TATA Binding Protein to a Naturally Positioned Nucleosome Is Facilitated by Histone Acetylation , 2001, Molecular and Cellular Biology.

[51]  Chawnshang Chang,et al.  Androgen Receptor Interacts with the Positive Elongation Factor P-TEFb and Enhances the Efficiency of Transcriptional Elongation* , 2001, The Journal of Biological Chemistry.

[52]  R. Evans,et al.  Regulation of Hormone-Induced Histone Hyperacetylation and Gene Activation via Acetylation of an Acetylase , 1999, Cell.

[53]  J. Shabanowitz,et al.  Androgen Receptor Phosphorylation , 2002, The Journal of Biological Chemistry.

[54]  Neil J. McKenna,et al.  Combinatorial Control of Gene Expression by Nuclear Receptors and Coregulators , 2002, Cell.

[55]  B. Katzenellenbogen,et al.  Direct Acetylation of the Estrogen Receptor α Hinge Region by p300 Regulates Transactivation and Hormone Sensitivity* , 2001, The Journal of Biological Chemistry.

[56]  E. Gelmann,et al.  Molecular biology of the androgen receptor. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[57]  V. Ogryzko,et al.  p300 and p300/cAMP-response Element-binding Protein-associated Factor Acetylate the Androgen Receptor at Sites Governing Hormone-dependent Transactivation* , 2000, The Journal of Biological Chemistry.